Appropriate FRAX® Intervention Threshold for Pharmacological Treatment of Osteoporosis in Thailand




FRAX® intervention threshold, Osteoporosis, Thailand, Major osteoporotic fracture, hip fracture


Purpose: The Fracture Risk Assessment Tool (FRAX®) has been recommended and incorporated into osteoporotic guidelines worldwide to assess fracture risk and promptly diagnose osteoporosis when bone mineral density is unavailable. However, a country-specific intervention threshold for Thai patients remains unknown. Therefore, we aimed to identify an appropriate cut-off point for the 10-year probability of hip fracture (HF), specifically in the Thai population.

Methods: This retrospective cohort study included members of the Thai population aged 50-90 years, enrolled from January 2018 to January 2020. Analysis of data collected from online FRAX® tool questionnaires was conducted and the receiver operating characteristic (ROC) curve was used to determine a new appropriate cut-off value as the intervention threshold.

Results: A total of 1,311 (HF: 422 [32.2%], non-HF: 889 [67.8%]) participants were included. The FRAX® 10-year probability of fracture in patients with HF was significantly higher than in non-HF (5.8% ± 4% vs. 4.7% ± 4.5%, respectively; P < 0.01), whereas the probability of major osteoporotic fracture (MOF) was similar (11.0 ± 5.8% vs. 10.6 ± 6.2%, P = 0.27). The ROC curve revealed a new intervention threshold for the FRAX®-based 10-year risk for HF of 4.3% with a maximum area under the curve (AUC) (95% confidence interval: 0.632 (range: 0.602-0.663; P < 0.001), with sensitivity and specificity of 62.9% and 60.7%, respectively.

Conclusions: The intervention threshold cut-off value for osteoporosis treatment among the Thai population was 4.3%, which is higher than the cut-off point recommended in the Thai national guidelines.


Metrics Loading ...


Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006;17:1726-33. DOI:

Mithal A, Bansal B, Kyer CS, et al. The Asia-Pacific Regional Audit-Epidemiology, Costs, and Burden of Osteoporosis in India 2013: A report of International Osteoporosis Foundation. Indian J Endocrinol Metab 2014;18: 449-54. DOI:

Chotiyarnwong P, Harvey NC, Johansson H, et al. Temporal changes in access to FRAX® in Thailand between 2010 and 2018. Arch Osteoporos 2019;14:66. DOI:

Kanis JA, Cooper C, Rizzoli R, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2019;30:3-44. DOI:

Kanis JA, Harvey NC, Cooper C, et al. A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 2016;11:25. DOI:

Chao AS, Chen FP, Lin YC, et al. Application of the World Health Organization Fracture Risk Assessment Tool to predict need for dual-energy X-ray absorptiometry scanning in postmenopausal women. Taiwan J Obstet Gynecol 2015;54:722-5. DOI:

Gadam RK, Schlauch K, Izuora KE. Frax prediction without BMD for assessment of osteoporotic fracture risk. Endocr Pract 2013;19: 780-4. DOI:

Pongchaiyakul C, Leerapun T, Wongsiri S, et al. Value and validation of RCOST and TOPF clinical practice guideline for osteoporosis treatment. J Med Assoc Thai 2012;95:1528-35.

Kallner A. Formulas. In: Kallner A, editor. Laboratory Statistics (Second Edition): Elsevier; 2018. p. 1-140. DOI:

Camacho PM, Petak SM, Binkley N, et al. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract 2020; 26(Suppl 1):1-46.

Pouresmaeili F, Kamalidehghan B, Kamarehei M, et al. A comprehensive overview on osteoporosis and its risk factors. Ther Clin Risk Manag 2018;14:2029-49. DOI:

McCloskey E, Kanis JA, Johansson H, et al. FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK. Osteoporos Int 2015;26:2091-9. DOI:

Sribenjalak D, Charoensri S, Pongchaiyakul C. An optimal intervention threshold of FRAX in postmenopausal Thai women. Arch Osteoporos 2022;17:21 DOI:

Cheung E, Cheung C-L, C Kung AW, et al. Possible FRAX-based intervention thresholds for a cohort of Chinese postmenopausal women. Osteoporos Int 2014;25:1017-23. DOI:

Fujiwara S, Nakamura T, Orimo H, et al. Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX). Osteoporos Int 2008;19:429-35. DOI:

Lekamwasam S. Sri Lankan FRAX model and country-specific intervention thresholds. Arch Osteoporos 2013;8:148. DOI:

Hwang J-S, Chan D-C, Chen J-F, et al. Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: summary. J Bone Miner Metab 2014;32:10-6. DOI:

Liu S-Y, Huang M, Chen R, et al. Comparison of strategies for setting intervention thresholds for Chinese postmenopausal women using the FRAX model. Endocrine 2019;65:200-6. DOI:

Yeap SS, Hew FL, Lee JK, et al. The Malaysian Clinical Guidance on the management of postmenopausal osteoporosis, 2012: a summary. Int J Rheum Dis 2013;16:30-40. DOI:




How to Cite

Amphansap T, Phan-udom C, Chotiyarnwong P, Stitkitti N, Therdyothin A. Appropriate FRAX® Intervention Threshold for Pharmacological Treatment of Osteoporosis in Thailand. JseaOrtho [Internet]. 2022 Oct. 8 [cited 2023 Feb. 3];47(1):11-7. Available from:



Original Articles